Effects of Curcumin on Tumor Growth and Muscle Mass in a Mouse Model of Cancer Cachexia

Donna McCarthy Beckett

Katrina Pycha

Thomas Berg

ONF 2008, 35(3), 455-459. DOI: 10.1188/08.ONF.455-459

Purpose/Objectives: To determine whether a diet containing 1% curcumin, a highly colored botanical food containing compounds that suppress expression of proinflammatory mediators implicated in the pathobiology of tumor-induced muscle wasting, would preserve muscle mass in two animal models of cancer cachexia.

Design: Four-group experimental design.

Setting: A health sciences animal care unit in the midwestern United States.

Sample: 60 female C57Bl/6 mice.

Methods: Mice were subcutaneously inoculated with Lewis lung carcinoma or B16 melanoma tumor cells. Curcumin was mixed into ground standard rodent food. The animals were fed the standard food or food with 1% curcumin for 17 days. Body weight and food intake were monitored and hind limb muscles, spleen, and tumor mass were weighed on day 17. Data were analyzed using two-way (tumor, diet) analysis of variance.

Main Research Variables: Body weight; plantaris, soleus, and gastrocnemius muscles relative to body weight; spleen; and tumor.

Findings: Food intake was not affected by 1% curcumin in the food. Tumor growth caused significant wasting of skeletal muscles in both animal models. Curcumin did not reduce splenomegaly or preserve body weight or muscle mass in either model, but curcumin did significantly reduced tumor mass in mice with B16 melanoma.

Conclusions: Curcumin may not be beneficial in the treatment of cancer cachexia; however, controlled clinical trials of curcumin in patients with cancer are warranted based on evidence of its antitumor effects in animal models.

Implications for Nursing: Patients frequently self-prescribe complementary and alternative substances after diagnosis and during cancer therapy. Answers to patients' questions about purported effects of these substances must include research findings when possible.

Jump to a section


    Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Molecular Pharmacology, 69(1), 195-206.
    Busquets, S., Carbo, N., Almendro, V., Quiles, M. T., Lopez-Soriano, F. J., & Argiles, J. M. (2001). Curcumin, a natural product present in tumeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer Letters, 167(1), 33-38.
    Deans, C., & Wigmore, S. J. (2005). Systemic inflammation, cachexia, and prognosis in patients with cancer. Current Opinion in Clinical Nutrition and Metabolic Care, 8(3), 265-269.
    Wallace, J. M. (2002). Nutritional and botanical modulation of the inflammatory cascade—eicosanoids, cyclo-oxygenases, and lipoxygenases—as an adjunct in cancer therapy. Integrative Cancer Therapies, 1(1), 7-37.
    Wyke, S. M., Russell, S. T., & Tisdale, M. J. (2004). Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. British Journal of Cancer, 91(9), 1742-1750.
    Adams, M., & Jewell, A. P. (2007, April). The use of complementary and alternative medicine by cancer patients. International Seminars in Surgical Oncology, 4, 10.
    Aggarwal, B. B., Sethi, G., Ahn, K. S., Sandur, S. K., Pandey, M. K., Kunemakkara, A. B., et al. (2006, December). Targeting signal-transducer-andactivator-of-transcription-3 for prevention and therapy of cancer: Modern target but ancient solution. Annals of the New York Academy of Sciences, 1091, 151-169.
    Aggarwal, B. B., & Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochemical Pharmacology, 71(10), 1397-1421.
    Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., et al. (2005). Curcumin suppresses the paclitaxel-induced nuclear factor-kB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clinical Cancer Research, 11(20), 7490-7498.
    DeJong, C. H., Busquets, S., Moses, A. G., Schreuwen, P., Ross, J. A., Argiles, J., et al. (2005). Systemic inflammation correlates with increased expression of skeletal muscle ubquitin but not uncoupling proteins in cancer cachexia. Oncology Reports, 14(1), 257-263.
    Durham, W. J., Arbogast, S., Gerkin, E., Li, Y. P., & Reid, M. B. (2006). Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice. Muscle and Nerve, 34(3), 298-303.
    Farid, M., Reid, M. B., Li, Y. P., Gerken, E., & Durham, W. J. (2005). Effects of dietary curcumin or N-acetylcysteine on NF-kB activity and contractile performance in ambulatory and unloaded murine soleus. Nutrition and Metabolism, 2(1), 20.
    Ferrari, C. K. (2004). Functional foods, herbs, and nutraceuticals: Toward biochemical mechanisms of healthy aging. Biogerontology, 5(5), 275-289.
    Garg, A. K., Buchholz, T. A., & Aggarwal, B. B. (2005). Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxidants and Redox Signaling, 7(11-12), 1630-1647.
    Graves, E., Ramsay, N., & McCarthy, D. O. (2006). Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma. Research in Nursing and Health, 29(2), 87-97.
    Harris, R. E. (2007). Cyclo-oxygenase-2 (COX-2) and the inflammogenesis of cancer. In R. E. Harris (Ed.), Inflammation in the pathogenesis of chronic diseases (pp. 93-126). Amsterdam, Netherlands: Springer.
    HemaIswarya, S., & Doble, M. (2006). Potential synergism of natural products in the treatment of cancer. Phytotherapy Research, 20(4), 239-249.
    Hong, J. H., Ahn, K. S., Bae, E., Jeon, S. S., & Choi, H. Y. (2006). The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer and Prostatic Diseases, 9(2), 147-152.
    Hsu, C. H., & Cheng, A. L. (2007). Clinical studies with curcumin. Advances in Experimental Medicine and Biology, 595, 471-480.
    Jeong, W. S., Kim, I. W., Hu, R., & Kong, A. N. (2004). Modulating properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharmacology Research, 21, 661-670.
    Jin, B., & Li, Y. P. (2007). Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. Journal of Cellular Biochemistry, 100(4), 960-969.
    Kunnamakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., & Aggarwal, B. B. (2007). Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB gene products. Cancer Research, 67(8), 3853-3861.
    Lai, V., George, J., Richey, L., Kim, H. J., Cannon, T., Shores, C., et al. (2008). Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck and gastrointestinal tract. Head and Neck, 30(1), 67-74.
    Lin, Y. G., Kunnumakkara, A. B., Nair, A., Merritt, W. M., Han, L. Y., Amaiz-Pena, G. N., et al. (2007). Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clinical Cancer Research, 13(11), 3423-3430.
    Lundholm, K., Daneryd, P., Korner, U., Hyltander, A., & Bosaeus, I. (2004). Evidence that long-term COX treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. International Journal of Oncology, 24(3), 505-512.
    McCarthy, D. O., & Graves, E. (2006). Conjugated linoleic acid preserves muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma. Research in Nursing and Health, 29(2), 98-104.
    McCarthy, D. O., Whitney, P., Hitt, A., & Al-Majid, S. (2004). Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon26 adenocarcinoma. Research in Nursing and Health, 27(3), 174-184.
    Nishino, H., Tokuda, H., Satomi, Y., Masuda, M., Osaka, Y., Yogosawa, S., et al. (2004). Cancer prevention by antioxidants. BioFactors, 22(1-4), 57-61.
    Perkins, S., Verschoyle, R. D., Hill, K., Parveen, I., Threadgill, M. D., Sharma, R. A., et al. (2002). Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiology Biomarkers and Prevention, 11(6), 535-540.
    Sharma, R. A., Gescher, A. J., & Steward, W. P. (2005). Curcumin: The story so far. European Journal of Cancer, 41(13), 1955-1968.
    Sharma, R. A., Steward, W. P., & Gescher, A. J. (2007). Pharmacokinetics and pharmacodynamics of curcumin. Advances in Experimental Medicine and Biology, 595, 453-470.
    Siwak, D. R., Shishodia, S., Aggarwal, B. B., & Kurzrock, R. (2005). Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer, 104(4), 879-890.
    Surh, Y. J. (2003). Cancer chemoprevention with dietary phytochemicals. Nature Reviews. Cancer, 3(10), 768-780.
    Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B. (2004). Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappB activation, inhibition of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene, 23(58), 9427-9458.
    Thomasset, S. C., Berry, D. P., Garcea, G., Marczylo, T., Steward, W. P., & Gescher, A. J. (2007). Dietary polyphenolic phytochemicals—Promising cancer chemopreventive agents in humans? A review of their clinical properties. International Journal of Cancer, 120(3), 451-458.
    Vapiwala, N., Mick, R., Hampshire, M. K., Meta, J. M., & Denittis, A. S. (2006). Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer Journal, 12(6), 467-474.